These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [On the situation of permit free self-production of radiopharmaceuticals in nuclear medicine]. Hoppe U; Machulla HJ; Neumaier B Nuklearmedizin; 2013; 52(5):N53-4. PubMed ID: 24085459 [No Abstract] [Full Text] [Related]
26. Regulating the tools of nuclear medicine. Hecht A FDA Consum; 1978 May; 12(4):6-12. PubMed ID: 10307464 [No Abstract] [Full Text] [Related]
27. [Formulations used in the preparation of radiopharmaceuticals at the department of nuclear medicine. I. General part]. Wiedermann M; Charamza O; Cífka J Cesk Farm; 1979 Sep; 28(7):306-7. PubMed ID: 535045 [No Abstract] [Full Text] [Related]
28. Therapeutic drug monitoring quality control for 1982. Lohff MR Pathologist; 1982 Feb; 36(2):66-7, 104. PubMed ID: 10254290 [No Abstract] [Full Text] [Related]
29. [Quality control experiences with commercial and noncommercial radiopharmaceuticals]. Strehlau E; Weiland J Radiobiol Radiother (Berl); 1980; 21(3):376-83. PubMed ID: 7455021 [No Abstract] [Full Text] [Related]
30. Cyclotron produced short-lived radioactive isotopes in nuclear medicine. Ter-Pogossian MM J Nucl Med; 1967 May; 8(5):374. PubMed ID: 6032683 [No Abstract] [Full Text] [Related]
33. Preparation, transfer for commercial distribution, and use of byproduct material for medical use--NRC. Final rule; clarification. Fed Regist; 1995 Jan; 60(2 Pt 1):322-5. PubMed ID: 10139994 [TBL] [Abstract][Full Text] [Related]
34. Report of an International Atomic Energy Agency's Advisory Group meeting on "Quality control of cyclotron-produced radiopharmaceuticals". Vera-Ruiz H; Marcus CS; Pike VW; Coenen HH; Fowler JS; Meyer GJ; Cox PH; Vaalburg W; Cantineau R; Helus F Int J Rad Appl Instrum B; 1990; 17(5):445-56. PubMed ID: 2391238 [No Abstract] [Full Text] [Related]
35. The usefulness of radiotracers to make the body biochemically transparent. Johannsen B Amino Acids; 2005 Dec; 29(4):307-11. PubMed ID: 15924214 [TBL] [Abstract][Full Text] [Related]
36. Quality control of packed raw materials in pharmaceutical industry. Rodionova OY; Sokovikov YV; Pomerantsev AL Anal Chim Acta; 2009 May; 642(1-2):222-7. PubMed ID: 19427480 [TBL] [Abstract][Full Text] [Related]
37. Quality assurance program for a nuclear pharmacy. Hiltz A; Pierce S Can J Hosp Pharm; 1991 Feb; 44(1):25-9. PubMed ID: 10110040 [TBL] [Abstract][Full Text] [Related]
38. [Tasks in the field of improving the quality of synthetic chemico-pharmaceutical preparations]. Zasosov VA Med Prom SSSR; 1966 Oct; 20(10):24-8. PubMed ID: 6000055 [No Abstract] [Full Text] [Related]
39. Committee E55 on process analytical technology: a supplier's perspective. Clegg I Stand News; 2004 May; 32(5):28-31. PubMed ID: 15146857 [No Abstract] [Full Text] [Related]
40. [Testing of radiopharmaceutic products derived from isotopic generators]. Cohen Y Ann Pharm Fr; 1971 Mar; 29(3):191-200. PubMed ID: 5562762 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]